<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00744198</url>
  </required_header>
  <id_info>
    <org_study_id>02/2008</org_study_id>
    <nct_id>NCT00744198</nct_id>
  </id_info>
  <brief_title>Autologous Versus Synthetic Versus Biological Sling for Trans-obturator Correction of Urinary Stress Incontinence</brief_title>
  <official_title>A Comparison in Terms of Efficacy and Safety Among Three Different Materials for Trans-obturator Correction of Urinary Stress Incontinence: Autologous, Synthetic and Biological Sling</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Magna Graecia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Magna Graecia</source>
  <brief_summary>
    <textblock>
      The treatment of urinary stress incontinence with trans-obturator approach, know as
      transobturatory tape (TOT), is a largely used sling-adopting procedures. The efficacy and
      safety of this minimally invasive surgery have been demonstrated, also in comparison with
      similar procedures, i.e transvaginal tape (TVT).

      To date the results of TOT in terms of efficacy and safety described in literature mainly
      refer to procedure in which synthetic materials are used, whereas few data regarding the use
      of biological materials are available. Moreover, despite the well known benefits of the
      available synthetic and eterologue kit, their use may be limited by the high cost of these
      materials. At this proposal it can be suggested as alternative option the possibility to
      perform the procedure using an autologous tissue, i.e. rectus fascia, and reusable
      introductory needles. Based on these considerations the aim of this trial will be to compare
      autologous, synthetic and biological mesh for TOT in women with urinary stress incontinence.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Women with genuine stress urinary incontinence will be enrolled and randomized in three
      groups (arm 1, arm 2, arm 3). All patients will be treated with a transobturatory approach,
      in patients of arm 1 will be used an autologous tissue and reusable introductory needles, in
      patients of arm 2 will be used a synthetic kit whereas in arm 3 will be a biological kit .

      All eligible patients will undergo baseline assessment consisting of anthropometric,
      clinical, hormonal, urodynamic, and ultrasonographic evaluations. During the study, the
      surgical outcomes, the clinical subjective and objective efficacy data, and the adverse
      experiences will be evaluated in each patient.

      Data will be analyzed using the intention-to-treat principle and a P value of 0.05 or less
      will be considered significant.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2012</start_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cure rate</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intra-operative complication rate</measure>
    <time_frame>one day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications rate</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Failure rate</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence rate</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sexual function</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">8</enrollment>
  <condition>Stress Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Autologous sling</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Synthetic sling</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Biological sling</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Autologous transobturator tape procedure</intervention_name>
    <description>A strip of rectus fascia is harvested. Small incision sites in the vagina and in the femoral/pelvic fold. Bilateral transobturator insertion of the autologous strip by means of reusable needles</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Synthetic transobturator tape procedure</intervention_name>
    <description>Small incision sites in the vagina and in the femoral/pelvic fold. Bilateral transobturator insertion of synthetic mesh by means of mono-use needles.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biological transobturator tape procedure</intervention_name>
    <description>Small incision sites in the vagina and in the femoral/pelvic fold. Bilateral transobturator insertion of biological mesh by means of mono-use needle</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Genuine stress urinary incontinence by self report, examination and test

          -  Urethral hypermobility

          -  Eligible for all three surgical procedures

          -  Ambulatory

        Exclusion Criteria:

          -  Pregnancy

          -  &lt;12 months post-partum

          -  Systemic disease and/or drugs known to affect bladder function

          -  Current chemotherapy or radiation therapy

          -  Urethral diverticulum, augmentation cytoplasty, or artificial sphincter

          -  Recent pelvic surgery

          -  Severe genuine stress incontinence (loss of urine with minimal physical activity) with
             associated prolapse equal to or more than second degree

          -  Previous pelvic or anti-incontinence surgery

          -  History of severe abdominopelvic infections

          -  Known extensive abdominopelvic adhesions

          -  Detrusor instability and/or intrinsic sphincter dysfunction

          -  Other gynaecologic pathologies (eg, fibroids, ovarian cysts)

          -  BMI &gt;30
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefano Palomba, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chair of Obstetrics and Gynecology, University &quot;Magna Graecia&quot; of Catanzaro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fulvio Zullo, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Chair of Obstetrics and Gynecology, University &quot;Magna Graecia&quot; of Catanzaro</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefano Palomba, MD</last_name>
    <email>stefanopalomba@tin.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>&quot;Pugliese&quot; Hospital</name>
      <address>
        <city>Catanzaro</city>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ingrid Tomaino, MD</last_name>
      <phone>39-096-188-3234</phone>
      <email>angela.falbo@libero.it</email>
    </contact>
    <investigator>
      <last_name>Stefano Palomba, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 26, 2008</study_first_submitted>
  <study_first_submitted_qc>August 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 29, 2008</study_first_posted>
  <last_update_submitted>April 5, 2013</last_update_submitted>
  <last_update_submitted_qc>April 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 8, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Magna Graecia</investigator_affiliation>
    <investigator_full_name>Stefano Palomba</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Autologous</keyword>
  <keyword>Biological</keyword>
  <keyword>Mesh</keyword>
  <keyword>Polypropylene</keyword>
  <keyword>Sling</keyword>
  <keyword>Synthetic</keyword>
  <keyword>Stress incontinence</keyword>
  <keyword>Surgery</keyword>
  <keyword>TOT</keyword>
  <keyword>Treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

